sight. However, a closer look on the methodological shortcomingsputstheirresultsintoperspective.
InthestudybyWeißflogetal. [2] ,patientsfromcertified cancercentreshadamuchshorterfollow-up(mean:78days sincelasttreatment)ascomparedtopatientsfromnon-certified hospitals (mean: 165 days). This difference is critical as qualityoflifeisveryfragileduringthefirstyearafterdiagnosis and usually does not follow a linear relation [4, 5] . Also, differences in participation rates have been reported by the authors(45vs.52%),whichmayresultinselectionbias.Likewise, differences in tumour stage are evident. Although the differences are not statistically significant and tumour stage has been considered as a confounder, dichotomization of stagemightnotbesufficienttoruleoutresidualconfounding within each category. In addition, differences in quality of stagingbetweencertifiedandnon-certifiedcentresmayintroduce additional bias. Similarly, there are differences in the twogroupsregardingtheproportionofrectalcancerpatients. Given the different treatment strategies between colon and rectalcancerpatients,failuretoadjustforthedifferentproportions of these cancers may also explain some differences with respect to quality of life. In addition, while adjuvant treatment is highly recommended for stage II and stage III rectalcancerandstageIIIcoloncancerpatients,recommendationsforstageIIcoloncancerareinconclusive,resultingin hugevariationwithrespecttotheapplicationinstageIIcolon cancer [6] .Withouttakingintoaccountinformationregarding therapy,interpretationoftheobserveddifferencesisverylimited. Further difficulties arise from the fact that the authors considereddepressionandanxietyasconfoundingfactorsand not as intermediate factors on the causal pathway because suchamodelwillyieldbiasedresultswithrespecttotheassociationbetweencancercareandqualityoflife.
To understand differences in the outcome of cancer patients from certified cancer centres as compared to patients from other hospitals, more information regarding the strucInterdisciplinary cancer centres aim to provide well-structuredinterdisciplinaryandevidence-basedcareofcancerpatients. Certification of cancer centres, which has been introducedinGermanyin2003bytheGermanCancerSocietyin ordertoimprovediagnosis,treatmentandfollow-upcareof cancer patients, is based on structural and process related criteria, such as numbers of operations and complications, training, adherence to evidence-based guidelines, interdisciplinary tumour boards and results of patient surveys and referrers.Theprocessofcertificationislinkedwiththeexpectation that improvements in structural and process related characteristicsinthetreatmentofcolorectalcanceralsoresult in better outcomes, such as recurrence free survival and healthrelatedqualityoflife.However,thereisonlylittleempiricalevidenceofaconnectionbetweenstructuralorganisation of cancer care and quality of life of colorectal cancer patientsandimprovementsinsurvivalratesmaycometothe foreonlyafteryears [1] .
In this issue of Onkologie, Weißflog et al. [2] compare qualityoflife,satisfactionanddistressincolorectalcancerpatientsfromcertifiedcentreswithpatientsfromnon-certified hospitals.Althoughpatientsfromcertifiedcentresweremore satisfiedwiththeirmedicalcarethanpatientstreatedinnoncertified hospitals, patients from certified centres tended reportlowerqualityoflifethantheirpeersleadingtheauthors totheconclusionthat'structuralimprovementsinoncological care are not necessarily reflected in better quality of life of patientstreatedincertifiedcolorectalcancercenters'.
Theauthors'findingthatpatientswhoaretreatedinacertified cancer centre report high levels of satisfaction with medicalcareisinlinewitharecentreportofPfaffetal. [3] studyingtheexperienceofbreastcancerpatientsinGermany. Incontrast,theirresults,showingnoclearbenefitinqualityof life among colorectal cancer patients treated in certified cancer centres as compared to patients from non-certified centres, may represent a sobering disappointment at first 
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